GC kinase Antibodies

Santa Cruz Biotechnology delivers a wide array of GC kinase monoclonal antibodies for investigating guanylate cyclase (GC) in various biological processes. GC kinase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Guanylate cyclase is a critical enzyme that catalyzes the conversion of GTP to cyclic GMP, a key signaling molecule involved in numerous physiological processes such as vasodilation, neurotransmission, and cellular signaling pathways. The regulation of cyclic GMP levels is essential for maintaining cardiovascular health and modulating smooth muscle relaxation. Understanding the function of guanylate cyclase and its associated pathways is vital for developing therapeutic strategies for various diseases. GC kinase monoclonal antibodies enable precise detection and analysis of guanylate cyclase expression and activity patterns. Researchers can effectively track guanylate cyclase localization and interactions within cellular compartments. Advanced visualization techniques using fluorescent conjugates like phycoerythrin (PE) and fluorescein isothiocyanate (FITC) enhance detection sensitivity. Santa Cruz Biotechnology monoclonal antibodies for GC kinase support cutting-edge research advancing our understanding of cardiovascular and neurological conditions.